Astrana Health (ASTH) Competitors

Astrana Health logo
$32.12 -0.75 (-2.28%)
As of 03:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ASTH vs. CHE, RDNT, LFST, BLLN, and OPCH

Should you buy Astrana Health stock or one of its competitors? Astrana Health's main competitors and comparable companies include Chemed (CHE), RadNet (RDNT), LifeStance Health Group (LFST), Billiontoone (BLLN), and Option Care Health (OPCH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Astrana Health compare to Chemed?

Astrana Health (NASDAQ:ASTH) and Chemed (NYSE:CHE) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

Astrana Health has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Chemed has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

Chemed has a net margin of 10.61% compared to Astrana Health's net margin of 1.36%. Chemed's return on equity of 35.18% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Astrana Health1.36% 11.57% 4.17%
Chemed 10.61%35.18%19.43%

Chemed has lower revenue, but higher earnings than Astrana Health. Chemed is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Astrana Health$3.91B0.47$22.49M$1.0730.72
Chemed$2.53B2.83$265.24M$20.9026.32

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Astrana Health had 1 more articles in the media than Chemed. MarketBeat recorded 3 mentions for Astrana Health and 2 mentions for Chemed. Astrana Health's average media sentiment score of 0.61 beat Chemed's score of 0.50 indicating that Astrana Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Astrana Health presently has a consensus target price of $50.38, suggesting a potential upside of 53.26%. Chemed has a consensus target price of $603.00, suggesting a potential upside of 9.60%. Given Astrana Health's stronger consensus rating and higher probable upside, research analysts clearly believe Astrana Health is more favorable than Chemed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
Chemed
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Summary

Astrana Health beats Chemed on 9 of the 16 factors compared between the two stocks.

How does Astrana Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Astrana Health (NASDAQ:ASTH) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

Astrana Health has a net margin of 1.36% compared to RadNet's net margin of -0.94%. Astrana Health's return on equity of 11.57% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.94% 3.14% 1.08%
Astrana Health 1.36%11.57%4.17%

Astrana Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.97-$18.65M-$0.29N/A
Astrana Health$3.91B0.47$22.49M$1.0730.72

In the previous week, RadNet had 10 more articles in the media than Astrana Health. MarketBeat recorded 13 mentions for RadNet and 3 mentions for Astrana Health. RadNet's average media sentiment score of 0.73 beat Astrana Health's score of 0.61 indicating that RadNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
3 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

RadNet presently has a consensus price target of $89.67, suggesting a potential upside of 16.62%. Astrana Health has a consensus price target of $50.38, suggesting a potential upside of 53.26%. Given Astrana Health's stronger consensus rating and higher probable upside, analysts clearly believe Astrana Health is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.78
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80

77.9% of RadNet shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

RadNet has a beta of 1.42, indicating that its stock price is 42% more volatile than the broader market. Comparatively, Astrana Health has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Summary

Astrana Health beats RadNet on 11 of the 17 factors compared between the two stocks.

How does Astrana Health compare to LifeStance Health Group?

Astrana Health (NASDAQ:ASTH) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

Astrana Health presently has a consensus target price of $50.38, suggesting a potential upside of 53.26%. LifeStance Health Group has a consensus target price of $14.86, suggesting a potential upside of 2.60%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts clearly believe Astrana Health is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Astrana Health has higher revenue and earnings than LifeStance Health Group. Astrana Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Astrana Health$3.91B0.47$22.49M$1.0730.72
LifeStance Health Group$1.42B3.87$9.66M$0.1976.21

LifeStance Health Group has a net margin of 4.29% compared to Astrana Health's net margin of 1.36%. Astrana Health's return on equity of 11.57% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Astrana Health1.36% 11.57% 4.17%
LifeStance Health Group 4.29%4.82%3.30%

In the previous week, LifeStance Health Group had 9 more articles in the media than Astrana Health. MarketBeat recorded 12 mentions for LifeStance Health Group and 3 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.61 beat LifeStance Health Group's score of 0.38 indicating that Astrana Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Astrana Health has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

Summary

Astrana Health beats LifeStance Health Group on 10 of the 17 factors compared between the two stocks.

How does Astrana Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Astrana Health (NASDAQ:ASTH) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, Billiontoone had 4 more articles in the media than Astrana Health. MarketBeat recorded 7 mentions for Billiontoone and 3 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.61 beat Billiontoone's score of 0.33 indicating that Astrana Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Billiontoone currently has a consensus target price of $124.38, suggesting a potential upside of 29.14%. Astrana Health has a consensus target price of $50.38, suggesting a potential upside of 53.26%. Given Astrana Health's stronger consensus rating and higher probable upside, analysts clearly believe Astrana Health is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80

52.8% of Astrana Health shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Astrana Health has higher revenue and earnings than Billiontoone. Astrana Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$436.87M10.53$7.45M$0.92104.68
Astrana Health$3.91B0.47$22.49M$1.0730.72

Billiontoone has a net margin of 10.95% compared to Astrana Health's net margin of 1.36%. Astrana Health's return on equity of 11.57% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Billiontoone10.95% 9.16% 6.78%
Astrana Health 1.36%11.57%4.17%

Summary

Astrana Health beats Billiontoone on 9 of the 15 factors compared between the two stocks.

How does Astrana Health compare to Option Care Health?

Astrana Health (NASDAQ:ASTH) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Astrana Health currently has a consensus target price of $50.38, indicating a potential upside of 53.26%. Option Care Health has a consensus target price of $29.48, indicating a potential downside of 7.04%. Given Astrana Health's stronger consensus rating and higher probable upside, research analysts plainly believe Astrana Health is more favorable than Option Care Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
Option Care Health
0 Sell rating(s)
14 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.13

Option Care Health has a net margin of 3.74% compared to Astrana Health's net margin of 1.36%. Option Care Health's return on equity of 19.06% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Astrana Health1.36% 11.57% 4.17%
Option Care Health 3.74%19.06%7.32%

In the previous week, Astrana Health had 1 more articles in the media than Option Care Health. MarketBeat recorded 3 mentions for Astrana Health and 2 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.65 beat Astrana Health's score of 0.61 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Astrana Health has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.47, suggesting that its share price is 53% less volatile than the broader market.

Option Care Health has higher revenue and earnings than Astrana Health. Option Care Health is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Astrana Health$3.91B0.47$22.49M$1.0730.72
Option Care Health$5.65B0.84$207.59M$1.3922.81

Summary

Option Care Health beats Astrana Health on 9 of the 16 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASTH vs. The Competition

MetricAstrana HealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.79B$10.57B$7.73B$11.61B
Dividend YieldN/A2.54%2.46%4.43%
P/E Ratio29.9735.8034.1629.83
Price / Sales0.462.088.475.65
Price / Cash11.2923.3421.9322.50
Price / Book2.063.594.373.65
Net Income$22.49M$332.46M$3.52B$392.18M
7 Day Performance-0.19%-4.09%-5.48%-4.27%
1 Month Performance-12.74%-1.81%-4.62%-6.75%
1 Year Performance52.73%18.67%-1.57%-7.22%

Astrana Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASTH
Astrana Health
3.4359 of 5 stars
$32.12
-2.3%
$50.38
+56.8%
+52.7%$1.79B$3.91B29.973,000
CHE
Chemed
3.5757 of 5 stars
$540.15
-0.8%
$603.00
+11.6%
+26.4%$7.02B$2.53B25.8015,811
RDNT
RadNet
3.542 of 5 stars
$78.45
+0.6%
$90.43
+15.3%
+2.3%$6.15B$2.04BN/A11,264
LFST
LifeStance Health Group
3.015 of 5 stars
$14.37
-1.3%
$13.75
-4.3%
+126.3%$5.48B$1.42B75.8210,961
BLLN
Billiontoone
3.4668 of 5 stars
$113.09
+1.0%
$124.38
+10.0%
+7.0%$5.35B$436.87M123.21713

Related Companies and Tools


This page (NASDAQ:ASTH) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners